Avalo Therapeutics
AVTX
AVTX
26 hedge funds and large institutions have $16M invested in Avalo Therapeutics in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
43% less capital invested
Capital invested by funds: $28M → $16M (-$12M)
Holders
26
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.75M | |
| 2 | +$1.05M | |
| 3 | +$831K | |
| 4 |
AC
Armistice Capital
New York
|
+$788K |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
+$700K |
Top Sellers
| 1 | -$95K | |
| 2 | -$79K | |
| 3 | -$7.59K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$6.58K |
| 5 |
Goldman Sachs
New York
|
-$1.69K |